Bio-Rad discloses Sartorius AG FY 2023 results: revenue €3.4B, net profit €290M

BIO-RAD LABORATORIES, INC.

Sartorius AG FY 2023 sales revenue €3,395.7M, gross profit €1,567.1M.
EBIT €503.9M, net profit €290.0M for the year ended Dec 31, 2023.
Operating cash flow €853.6M; investing cash flow -€2,823.3M; financing cash flow €2,165.7M.
Total assets €9,755.4M, equity €2,757.4M as of Dec 31, 2023.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.